Lexicon Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $85.3M | $134.6M | $2.5M |
| Jun 2017 | $85.4M | $106.3M | $30.7M |
| Sep 2017 | $85.5M | $78.4M | $83.3M |
| Dec 2017 | $231.6M | $68.3M | $61.7M |
| Mar 2018 | $231.9M | $26.2M | $20.4M |
| Jun 2018 | $232.2M | $-5.1M | $48.9M |
| Sep 2018 | $243.8M | $-29.4M | $48.9M |
| Dec 2018 | $243.9M | $-26.4M | $80.4M |
| Mar 2019 | $243.9M | $-45.7M | $45.8M |
| Jun 2019 | $244.0M | $-64.9M | $11.1M |
| Sep 2019 | $233.8M | $164.7M | $170.2M |
| Dec 2019 | $234.2M | $117.1M | $36.1M |
| Mar 2020 | $234.5M | $54.8M | $55.6M |
| Jun 2020 | $234.8M | $-10.7M | $86.9M |
| Sep 2020 | $11.6M | $87.6M | $52.3M |
| Dec 2020 | $0 | $156.4M | $126.3M |
| Mar 2021 | $1.7M | $152.5M | $97.7M |
| Jun 2021 | $1.6M | $137.2M | $89.9M |
| Sep 2021 | $1.5M | $136.6M | $92.1M |
| Dec 2021 | $0 | $113.6M | $64.1M |
| Mar 2022 | $23.5M | $92.7M | $59.5M |
| Jun 2022 | $23.6M | $70.8M | $21.5M |
| Sep 2022 | $23.8M | $144.0M | $18.8M |
| Dec 2022 | $48.6M | $117.1M | $46.3M |
| Mar 2023 | $48.8M | $88.0M | $26.0M |
| Jun 2023 | $98.8M | $186.4M | $102.3M |
| Sep 2023 | $99.3M | $139.5M | $21.1M |
| Dec 2023 | $99.5M | $93.1M | $22.5M |
| Mar 2024 | $99.9M | $288.9M | $96.5M |
| Jun 2024 | $99.5M | $240.0M | $35.6M |
| Sep 2024 | $99.9M | $178.5M | $34.6M |
| Dec 2024 | $100.3M | $146.0M | $66.7M |
| Mar 2025 | $58.6M | $123.0M | $62.9M |
| Jun 2025 | $56.1M | $129.4M | $21.4M |
| Sep 2025 | $56.5M | $120.2M | $49.7M |
| Dec 2025 | $49.4M | $107.5M | $34.3M |
| Mar 2026 | $49.7M | $202.9M | $38.1M |
| Jun 2026 | $51.4M | $174.5M | $40.9M |